*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Study of Some SNPs for PIK3CA Gene in Laryngeal Cancer Cells line (HEP-2)

Author: LUBNA SAMI ALI, NISREEN J.MOHAMMED, RANA A.GHALEB, SHAIMAA A. AL-OUBAIDY
Abstract: Mutations of the phosphatidyl-inositol 3-kinase (PI3k) Pathway in the head and neck squamous cell carcinoma ( HNSCC) may accelerate the malignant cells formation which is already genetically aberrant, resulting in further genomic aberrations in known cancer genes. The PI3KCA gene, which codes the catalytic subunit p110a, is one of the important mutated oncogenes found in human cancers and considered as a tool for diagnostic and therapeutic targets. The results of the sequence of PCR products of amplified gene PI3KCA in the hep2 cell line include three detected SNPs and were found to be previously known as rs138281424, rs1057519925, and rs751920344 for the detected G535A, G703A, and T606C, respectively. PIK3CA was a serious potential target for pathway-specific, kinase-inhibitor-based therapies in laryngeal cancer.
Keyword: Cancer, Study, line
DOI: https://doi.org/10.31838/ijpr/2020.SP1.299
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free